Product Information

GRALISE ER 600 MG TABLET is a brand product labeled by Almatica Pharma LLC, priced at $10.1632 per EA under NDC 52427080690. Its NADAC has been published 272 times since Apr 14, 2021.

The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GRALISE ER 600 MG TABLET

gabapentin
$10.1632per EA
High Outlier

Strength

600 mg/1

NDC

52427080690

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

GABAPENTIN

Approval Type

New Drug (NDA)

FDA Application

NDA022544

On Market Since

10/1/2020

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GRALISE ER 600 MG TABLET has been published 272 times since Apr 14, 2021, and over the history we have for it it has risen 14.1%. The table below summarizes its recorded NADAC range and movement.

Current price$10.1632 per EA
All-time high$10.2037 (Oct 15, 2025)
All-time low$8.9110 (Apr 14, 2021)
52-week high$10.2037
52-week low$10.1620
Median price$10.1678
Average price$9.9077
Largest weekly change+6.0% (May 4, 2022)
Weeks tracked272
Tracking sinceApr 14, 2021

Price History

1W

0.0%

1M

-0.0%

3M

+0.0%

6M

-0.1%

1Y

-0.4%

3Y

-0.1%

5Y

+10.5%

All

+14.1%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GRALISE ER 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GRALISE ER 600 MG TABLET, manufactured by Almatica Pharma LLC, is $10.1632 per EA (NDC 52427080690), effective Jun 24, 2026.

How has the price of GRALISE ER 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GRALISE ER 600 MG TABLET has risen 14.1%. It has been tracked across 272 weekly CMS publications since Apr 14, 2021.

What are the highest and lowest recorded NADAC prices for GRALISE ER 600 MG TABLET?

Since Apr 14, 2021, the NADAC for GRALISE ER 600 MG TABLET has ranged from a low of $8.9110 (Apr 14, 2021) to a high of $10.2037 (Oct 15, 2025), with a median of $10.1678 per EA.

Are there cheaper alternatives to GRALISE ER 600 MG TABLET?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 600 MG TABLET, is $0.0668 per EA — about 99% below GRALISE ER 600 MG TABLET.

Who manufactures GRALISE ER 600 MG TABLET?

GRALISE ER 600 MG TABLET (NDC 52427080690) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.